Listar por tema "interstitial lung disease"
Mostrando ítems 1-1 de 1
-
Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies
(Seminars in Arthritis and Rheumatism, 2023)Objective: To compare the efficacy, toxicity and glucocorticoid (GC)-sparing effects of intravenous cyclophosphamide (iv CYC) with other immunosuppressive regimes as the induction treatment for Idiopathic Inflammatory ...